// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Determining the Minimal Clinically Important Difference (MCID) for the PEmbQoL Questionnaire, A Measure of PE-Specific Quality of Life

A. Akaberi - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Predictors of Post-Discharge Outcomes and Care-Seeking Behaviors among Children with Acute Infectious Illness in Southwestern Uganda

P. P. Moschovis - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

Ventilator Associated Complications: Development and Validation of an Automated Detection Algorithm and Application in a Population-Based Cohort of Adult Critical Care Patients in Alberta

D. C. Vis - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Clinical Efficacy and Safety of CFTR-Directed Therapies in Cystic Fibrosis: A Systematic Review and Meta-Analysis

A. Habib - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

N/A

Intracellular Persistence of Pseudomonas Aeruginosa in Airway Epithelial Cells and in Cystic Fibrosis Lung

E. Faure - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

Tobramycin

A Systematic Review of Interventions for Smoking Tobacco in Low Socio-Economic Populations

C. B. Charron - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Host Matricellular Protein Thrombospondin-1 Limits Extracellular Matrix Proteolysis During Acute Pseudomonas Aeruginosa-Induced Lung Injury

Y. Qu - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

thrombospondin-1

Education of Stem Cells by BCG: An Innovative Approach in TB Vaccine Development

E. Kaufmann - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Increases in Heart Sound Intensity Following Respiratory Events Are Positively Correlated with Drops in Oxygen Saturation During the Events

M. M. Kabir - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Monitoring COPD Disease Activity for Personalized, Preventative Treatment

V. Chen - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Clinical Efficacy and Safety of Fluoroquinolone-Containing Regimens in Patients with Mycobacterium Avium Complex (MAC) Pulmonary Disease

H. Khadawardi - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

Fluoroquinolone

Blood Eosinophil Levels in First Hospitalization for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) Are Associated with Increased COPD-Related Readmissions

M. Belanger - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

The Characteristics and Significance of Low Density Neutrophils (LDN): A New and Unique Sub-Population of Circulating Neutrophils, in Human Lung Cancer

Z. G. Fridlender - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

PD-L1 Testing of EBUS-TBNA Samples Acquired for the Diagnosis and Staging of Non-Small Cell Lung Cancer: Feasibility and Results

A. Smith - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Pembrolizumab

Long Noncoding RNA H19 in the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure

J. Omura - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Pyruvate Dehydrogenase Kinase-Mediated Mitochondrial Metabolism and Fission in Right Ventricular Fibroblasts Promote Right Ventricular Fibrosis in Experimental Pulmonary Arterial Hypertension

L. Tian - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Dichloroacetate

Diaphragmatic Activity of Extremely Preterm Infants During the Peri-Extubation Period

S. Latremouille - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prevention of Ventilator Induced Lung Injury by Total Liquid Ventilation in an Ovine Neonatal Model of Induced Surfactant Deficiency

M. Sage - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Digibind

Viral Load, Telomere Length and Microbial Communities in the Gut Lung Axis of HIV Donors

J. Yang - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Lung Cancer Risks Across Different Industries and Occupations in Ontario, Canada: The Establishment of the Occupational Disease Surveillance System (ODSS)

V. H. Arrandale - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved